10-Year Follow-Up: Pembrolizumab Outshines Ipilimumab in Advanced Melanoma
Long-term study shows pembrolizumab's superior efficacy over ipilimumab for advanced melanoma patients.
Chronic Myeloid Leukemia
3 articles
ASC2ESCALATE: Exploring Asciminib's Potential in Early-Stage CML Treatment
Phase II trial evaluates asciminib for first- and second-line therapy in chronic myeloid leukemia.
New Analysis Supports Flexible Dosing Options for CML Drug Asciminib
Study shows similar efficacy and safety for once-daily and twice-daily asciminib dosing in CML patients.
Fosfomycin vs Ciprofloxacin: A New Approach to Prevent Infections in High-Risk Blood Cancer Patients
Study compares fosfomycin to ciprofloxacin for preventing infections in leukemia and transplant patients